The Supreme Court said on Friday that the case of actor Rhea Chakraborty against Sushant Singh Rajput’s sister Priyanka Singh would not be dropped. Chakraborty had accused Priyanka of arranging a fake prescription to help Sushant gain access to banned drugs. The CBI will now take over the case and investigate the matter, as the SC had previously ruled that all FIRs linked to Sushant’s death would be investigated by the Central Investigation Agency.
Rheya Chakraborty, who is being investigated by a number of central agencies after Sushant Singh Rajput’s family accused her of involvement in the actor’s death, has filed a complaint against Rajput’s sisters Priyanka and Mitu Singh. The nurses were charged with falsifying and violating the NDPS Drugs and Psychotropic Substances Act based on a Chakraborty complaint.
Chakraborty filed a complaint based on Whatsapp texts exchanged between Sushant and Priyanka Singh on June 8, six days before his death. According to the chat, Priyanka advised her brother to take three drugs – Librium, Mexito and Lonazep. They are prescribed for depression and anxiety, but are not bought without a prescription and require a prescription.
On February 15, the Bombay Supreme Court said the investigation against Priyanka Singh would continue until the case against Mitu Singh was dropped. On Friday, Priyanka’s lawyer argued in the SC that there was no evidence that Sushant had consumed the drug. She also said in her petition that the doctor she consulted was qualified to prescribe the medication through teleconsultation.
READ ALSO: Sushant Singh Rajput case: NCB submits 12,000 pages
Catch our latest Bollywood news, update new Bollywood movies, box office collection, new movie release, Bollywood Hindi news, entertainment news, Bollywood news today and upcoming 2020 movies and stay up to date with the most new Hindi movies only on Bollywood Hungama.